280 related articles for article (PubMed ID: 20943659)
41. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.
Donato R
Curr Mol Med; 2007 Dec; 7(8):711-24. PubMed ID: 18331229
[TBL] [Abstract][Full Text] [Related]
42. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
[TBL] [Abstract][Full Text] [Related]
43. Structural insights into the interaction of human S100B and basic fibroblast growth factor (FGF2): Effects on FGFR1 receptor signaling.
Gupta AA; Chou RH; Li H; Yang LW; Yu C
Biochim Biophys Acta; 2013 Dec; 1834(12):2606-19. PubMed ID: 24063890
[TBL] [Abstract][Full Text] [Related]
44. The role of receptor for advanced glycation end products (RAGE) in neuronal differentiation.
Kim J; Wan CK; J O'Carroll S; Shaikh SB; Nicholson LF
J Neurosci Res; 2012 Jun; 90(6):1136-47. PubMed ID: 22344976
[TBL] [Abstract][Full Text] [Related]
45. Structural characterization of S100A15 reveals a novel zinc coordination site among S100 proteins and altered surface chemistry with functional implications for receptor binding.
Murray JI; Tonkin ML; Whiting AL; Peng F; Farnell B; Cullen JT; Hof F; Boulanger MJ
BMC Struct Biol; 2012 Jul; 12():16. PubMed ID: 22747601
[TBL] [Abstract][Full Text] [Related]
46. Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo.
Hoppmann S; Steinbach J; Pietzsch J
Int J Biochem Cell Biol; 2010 May; 42(5):651-61. PubMed ID: 20025991
[TBL] [Abstract][Full Text] [Related]
47. Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product.
Mohammed A; Zeng W; Mengist HM; Kombe Kombe AJ; Ou H; Yang Y; Dan Z; Xu Z; Ma H; Jin T
Biochem Biophys Res Commun; 2021 Dec; 581():38-45. PubMed ID: 34653677
[TBL] [Abstract][Full Text] [Related]
48. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells.
Hsieh HL; Schäfer BW; Weigle B; Heizmann CW
Biochem Biophys Res Commun; 2004 Apr; 316(3):949-59. PubMed ID: 15033494
[TBL] [Abstract][Full Text] [Related]
49. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
Bongarzone S; Savickas V; Luzi F; Gee AD
J Med Chem; 2017 Sep; 60(17):7213-7232. PubMed ID: 28482155
[TBL] [Abstract][Full Text] [Related]
50. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.
Teissier T; Boulanger É
Biogerontology; 2019 Jun; 20(3):279-301. PubMed ID: 30968282
[TBL] [Abstract][Full Text] [Related]
51. Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli.
Wilton R; Yousef MA; Saxena P; Szpunar M; Stevens FJ
Protein Expr Purif; 2006 May; 47(1):25-35. PubMed ID: 16510295
[TBL] [Abstract][Full Text] [Related]
52. Ousting RAGE in melanoma: A viable therapeutic target?
Syed DN; Aljohani A; Waseem D; Mukhtar H
Semin Cancer Biol; 2018 Apr; 49():20-28. PubMed ID: 29079306
[TBL] [Abstract][Full Text] [Related]
53. Ligand binding affinity and changes in the lateral diffusion of receptor for advanced glycation endproducts (RAGE).
Syed A; Zhu Q; Smith EA
Biochim Biophys Acta; 2016 Dec; 1858(12):3141-3149. PubMed ID: 27720951
[TBL] [Abstract][Full Text] [Related]
54. RAGE Signaling in Melanoma Tumors.
Olaoba OT; Kadasah S; Vetter SW; Leclerc E
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256110
[TBL] [Abstract][Full Text] [Related]
55. Modeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance for early neuropathological processes.
Serratos IN; Castellanos P; Pastor N; Millán-Pacheco C; Rembao D; Pérez-Montfort R; Cabrera N; Reyes-Espinosa F; Díaz-Garrido P; López-Macay A; Martínez-Flores K; López-Reyes A; Sánchez-García A; Cuevas E; Santamaria A
PLoS One; 2015; 10(3):e0120221. PubMed ID: 25757085
[TBL] [Abstract][Full Text] [Related]
56. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
Basta G
Atherosclerosis; 2008 Jan; 196(1):9-21. PubMed ID: 17826783
[TBL] [Abstract][Full Text] [Related]
57. The crystal structures of human S100B in the zinc- and calcium-loaded state at three pH values reveal zinc ligand swapping.
Ostendorp T; Diez J; Heizmann CW; Fritz G
Biochim Biophys Acta; 2011 May; 1813(5):1083-91. PubMed ID: 20950652
[TBL] [Abstract][Full Text] [Related]
58. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
59. Identification of pyridinoline, a collagen crosslink, as a novel intrinsic ligand for the receptor for advanced glycation end-products (RAGE).
Murakami Y; Fujino T; Kurachi R; Hasegawa T; Usui T; Hayase F; Watanabe H
Biosci Biotechnol Biochem; 2018 Sep; 82(9):1508-1514. PubMed ID: 29804507
[TBL] [Abstract][Full Text] [Related]
60. The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine.
Leclerc E; Heizmann CW
Front Biosci (Schol Ed); 2011 Jun; 3(4):1232-62. PubMed ID: 21622268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
